The request for previously authorized drugs to be reviewed by the German Federal Joint Committee (GBA) is legal, decided the Superior State Social Court (LSG Berlin-Brandenburg) February 28, 2013 under reference number: L 7 KA 106/12 KL ER. The pharmaceutical … Weiterlesen
GERMAN HEALTH CARE MARKET: Novartis lost its lawsuit against German Federal Joint Committee (GBA)
↧
↧
